Select trials in KMT2Ar ALL
| Target . | Agent . | Clinical trial # . | Phase . | Age . | Disease status . | Results . |
|---|---|---|---|---|---|---|
| Menin | SNDX-5613 (revumenib) | NCT04065399 | 1/2 | >30 d | R/R | Issa et al22 |
| Menin | SNDX-5613 (revumenib) | NCT05326516 | 1 | >30 d | R/R | N/A |
| Menin | BMF-219 | NCT05153330 | 1 | 18 + y | R/R | Ravandi et al57 |
| Menin | DSP-5336 | NCT04988555 | 1/2 | 18 + y | R/R | Daver et al58 |
| Menin | JNJ-75276617 | NCT05521087 | 1/1b | 30 d–30 y | R/R | N/A |
| Target . | Agent . | Clinical trial # . | Phase . | Age . | Disease status . | Results . |
|---|---|---|---|---|---|---|
| Menin | SNDX-5613 (revumenib) | NCT04065399 | 1/2 | >30 d | R/R | Issa et al22 |
| Menin | SNDX-5613 (revumenib) | NCT05326516 | 1 | >30 d | R/R | N/A |
| Menin | BMF-219 | NCT05153330 | 1 | 18 + y | R/R | Ravandi et al57 |
| Menin | DSP-5336 | NCT04988555 | 1/2 | 18 + y | R/R | Daver et al58 |
| Menin | JNJ-75276617 | NCT05521087 | 1/1b | 30 d–30 y | R/R | N/A |